PHD-1-IN-1

Research use only, not for human use.

PHD-1-IN-1 is a potent inhibitor of hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme(IC50 = 0.034 μM).

PHD-1-IN-1 is a potent inhibitor of hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme(IC50 = 0.034 μM).(In Vivo):Administration of PHD-1-IN-1 (3 mg/kg of p.o. or 0.5 mg/kg of i.v.) has a Cmax of 0.8 μM, a AUC of 176 ng h/mL, Kp,uu of 1.11 and B/P of 0.95.

——

PHD-1-IN-1 (compound 17; 3 mg/kg of p.o. or 0.5 mg/kg of i.v.) has a Cmax of 0.8 μM, a AUC of 176 ng?h/mL, Kp,uu of 1.11 and B/P of 0.95. Animal Model:Male C57BL6 mice Dosage:3 mg/kg (p.o.) or 0.5 mg/kg (i.v.) (Pharmacokinetic Analysis) Administration:PO or IV Result:Had a Cmax of 0.8 μM, a AUC of 176 ng?h/mL, Kp,uu of 1.11 and B/P of 0.95.

——

Angiogenesis

HIF/HIF Prolyl-hydroxylase

——

——

——

2009343-14-8

220.23

C13H8N4

>98% (HPLC)

In Vitro:?DMSO : 195 mg/mL (885.44 mM)

N#Cc(cc1)ccc1-c1cccc2ncnn12

——

(-20℃)

With Ice Pack

≥ 2 years